🐜
|
Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel.
32 auth.
A. Sturm,
J. Knowles,
S. Gidding,
Z. Ahmad,
C. Ahmed,
C. Ballantyne,
S. Baum,
M. Bourbon,
A. Carrié,
M. Cuchel,
S. D. de Ferranti,
J. Defesche,
T. Freiberger,
R. Hershberger,
G. Hovingh,
...
L. Karayan,
J. Kastelein,
I. Kindt,
S. Lane,
S. Leigh,
M. Linton,
P. Mata,
W. Neal,
B. Nordestgaard,
R. Santos,
M. Harada‐Shiba,
E. Sijbrands,
N. Stitziel,
S. Yamashita,
K. Wilemon,
D. Ledbetter,
D. Rader
|
8 |
2018 |
8 🐜
|
🐜
|
Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype-phenotype relationship, and clinical outcome.
13 auth.
B. Sjouke,
D. Kusters,
I. Kindt,
J. Besseling,
J. Defesche,
E. Sijbrands,
J. E. Roeters van Lennep,
A. Stalenhoef,
A. Wiegman,
J. de Graaf,
...
S. Fouchier,
J. Kastelein,
G. Hovingh
|
8 |
2015 |
8 🐜
|
🐜
|
Frequency of Pregnancy-Related Venous Thromboembolism in Anticoagulant Factor-Deficient Women: Implications for Prophylaxis
10 auth.
P. Friederich,
B. Sanson,
P. Simioni,
S. Zanardi,
M. Huisman,
I. Kindt,
...
P. Prandoni,
H. Buller,
A. Girolami,
M. Prins
|
7 |
1996 |
7 🐜
|
🐬
|
Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: a study of a cohort of 14,000 mutation carriers.
J. Besseling,
I. Kindt,
M. Hof,
J. Kastelein,
B. Hutten,
G. Hovingh
|
7 |
2014 |
7 🐬
|
🐜
|
Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry
50 auth.
H. Schwertz,
M. Rondina,
J. Millar,
Beauséjour Ladouceur,
D. Abrams,
Wei Wang,
S. Oh,
M. Koester,
Sandra Abramowicz,
Nan Wang,
A. Tall,
E. Theusch,
Celia C. Cubitt,
A. Dosé,
K. Stevens,
...
Devesh Naidoo,
G. D. Smith,
M. Ala-Korpela,
J. Kettunen,
P. Würtz,
P. Soininen,
A. Kangas,
C. Dale,
D. Lawlor,
T. Gaunt,
Emil M Degoma,
Z. Ahmad,
Emily C. O'Brien,
I. Kindt,
P. Shrader,
C. Newman,
Y. Pokharel,
S. Baum,
L. Hemphill,
L. Hudgins,
C. Ahmed,
S. Gidding,
Danielle Duffy,
W. Neal,
K. Wilemon,
M. Roe,
D. Rader,
C. Ballantyne,
M. Linton,
P. Duell,
P. Moriarty,
Chenyi Xue,
R. McPherson,
H. Watkins,
H. Schunkert
|
7 |
2016 |
7 🐜
|
🐜
|
Two Years after Molecular Diagnosis of Familial Hypercholesterolemia: Majority on Cholesterol-Lowering Treatment but a Minority Reaches Treatment Goal
7 auth.
R. Huijgen,
I. Kindt,
Sjoerd B. J. Verhoeven,
Eric J G Sijbrands,
M. N. Vissers,
J. Kastelein,
...
B. Hutten
|
6 |
2010 |
6 🐜
|
🐜
|
Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.
19 auth.
Emily C. O'Brien,
M. Roe,
Elizabeth S. Fraulo,
E. Peterson,
C. Ballantyne,
J. Genest,
S. Gidding,
E. Hammond,
L. Hemphill,
L. Hudgins,
...
I. Kindt,
P. Moriarty,
J. Ross,
James A Underberg,
K. Watson,
D. Pickhardt,
D. Rader,
K. Wilemon,
J. Knowles
|
6 |
2014 |
6 🐜
|
🐬
|
Cardiovascular risk in relation to functionality of sequence variants in the gene coding for the low-density lipoprotein receptor: a study among 29,365 individuals tested for 64 specific low-density lipoprotein-receptor sequence variants.
R. Huijgen,
I. Kindt,
J. Defesche,
J. Kastelein
|
6 |
2012 |
6 🐬
|
🐬
|
Discriminative Ability of LDL-Cholesterol to Identify Patients With Familial Hypercholesterolemia: A Cross-Sectional Study in 26 406 Individuals Tested for Genetic FH
R. Huijgen,
B. Hutten,
I. Kindt,
M. N. Vissers,
J. Kastelein
|
6 |
2012 |
6 🐬
|
🐜
|
Health disparities among adult patients with a phenotypic diagnosis of familial hypercholesterolemia in the CASCADE-FH™ patient registry.
31 auth.
S. Amrock,
P. Duell,
T. Knickelbine,
S. Martin,
Emily C. O'Brien,
K. Watson,
J. Mitri,
I. Kindt,
P. Shrader,
S. Baum,
L. Hemphill,
C. Ahmed,
Rolf L. Andersen,
I. Kullo,
Dervilla McCann,
...
J. Larry,
M. Murray,
R. Fishberg,
J. Guyton,
K. Wilemon,
M. Roe,
D. Rader,
C. Ballantyne,
James A Underberg,
P. Thompson,
D. Duffy,
M. Linton,
M. Shapiro,
P. Moriarty,
J. Knowles,
Z. Ahmad
|
6 |
2017 |
6 🐜
|